EUVIMEDEUVIMED entdecken
Crossref

Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology

Satyam N Patel iD, Chetan K Kajavadara iD, Rushikesh M Shukla iD, Darshan T Valani iD, Laxit K Bhatt iD, Rajesh Sundar, Mukul R Jain iD

Journal of Applied Toxicology · 2026

DOI: 10.1002/jat.4894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Satyam N Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India. Hauptthemen laut MEDLINE: Chromosome Aberrations, Solvents, Lymphocytes, Mutagens. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Zydus Lifesciences Limited, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The chromosome aberration test (CAT) is a widely used in vitro assay for detecting structural chromosomal damage induced by clastogenic chemicals. It plays a crucial role in genetic toxicology, helping assess the potential genotoxic effects of pharmaceutical compounds, environmental contaminants, and industrial chemicals. This test is particularly valuable in regulatory studies, as chromosomal aberrations are linked to mutagenicity, carcinogenicity, and hereditary diseases. The test evaluates their occurrence in cultured human peripheral blood lymphocytes (HPBL) or other mammalian cells after exposure to test chemicals. Accurate solubility of test compounds is critical for determining the highest feasible concentration in CAT without compromising cell viability or assay integrity. However, selecting an appropriate solvent remains a challenge in genetic toxicology, as the solvent must ensure chemical stability, support cell growth and metabolic activation, comprise ≤ 1% of the final treatment medium, and be compatible with human blood cells. In this study, we systematically evaluated the cytotoxic effects of various solvents on HPBL at 0.5% and 1% concentrations over a 22‐h exposure period, replicating approximately 1.5 normal cell cycle durations without the inclusion of a metabolic activation system. The solvents tested included dimethyl sulfoxide (DMSO), N , N ‐dimethylformamide (DMF), acetone, acetonitrile, ethyl acetate, ethanol, methanol, p ‐dioxane, tetrahydrofuran (THF), and dimethylacetamide. Our findings revealed that N , N ‐dimethylformamide and acetone were noncytotoxic at 0.5%, while ethanol, methanol, acetonitrile, and dimethyl sulfoxide were noncytotoxic at both 0.5% and 1% concentrations, whereas other solvents exhibited cytotoxic effects at both concentrations. These findings provide valuable insights for genetic toxicologists, enabling better selection of optimal solvents for CAT‐based genotoxicity assessments. By refining solvent choices, researchers can improve chromosome aberration analysis accuracy, facilitating more reliable regulatory decision‐making in genetic toxicology and pharmaceutical safety evaluations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosome AberrationsSolventsLymphocytesMutagensHumansMutagenicity TestsCells, CulturedCell SurvivalDose-Response Relationship, DrugDimethyl Sulfoxide

Stichwörter der Autor:innen

chromosome aberration testcytotoxicityperipheral blood lymphocytessolubilitysolvents

Substanzen

SolventsMutagensDimethyl Sulfoxide

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Zydus Research Centre, Zydus Lifesciences Limited, Ahmedabad, India.

ORCID-Profile: Satyam N Patel, Chetan K Kajavadara, Rushikesh M Shukla, Darshan T Valani, Laxit K Bhatt, Mukul R Jain

Förderung

  • Zydus Lifesciences Limited, India

Zitieren

APA

Patel, S. N., Kajavadara, C. K., Shukla, R. M., Valani, D. T., Bhatt, L. K., Sundar, R., & Jain, M. R. (2026). Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4894

Vancouver

Patel SN, Kajavadara CK, Shukla RM, Valani DT, Bhatt LK, Sundar R, et al. Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology. Journal of Applied Toxicology. 2026. doi:10.1002/jat.4894

BibTeX
@article{Patel2026,
  author = {Patel, Satyam N and Kajavadara, Chetan K and Shukla, Rushikesh M and Valani, Darshan T and Bhatt, Laxit K and Sundar, Rajesh and Jain, Mukul R},
  title = {Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology},
  journal = {Journal of Applied Toxicology},
  year = {2026},
  doi = {10.1002/jat.4894}
}
Kostenlos starten →